Bullfrog Ai Holdings, INC 10-Q quarterly reports
Quarterly reports, with unaudited financial statements and management’s discussion of the quarter just ended.
NASDAQ
BullFrog AI Holdings, Inc. reports Q1 2026 results, highlighting increased cash reserves from equity financing, ongoing efforts to regain Nasdaq compliance, and continued R&D investment.
NASDAQ
BullFrog AI Holdings, Inc. reported a significant decrease in cash and equity, triggering a Nasdaq non-compliance notice, despite recognizing its first collaboration revenue.
NASDAQ
Bullfrog AI Holdings, Inc. reported a net loss of $1.45 million for Q2 2025 and disclosed substantial doubt about its ability to continue as a going concern due to insufficient cash to fund operations for the next year.
NASDAQ
Bullfrog AI Holdings reports its Q1 2025 financial results, highlighting a net loss and raising concerns about its ability to continue as a going concern.
NASDAQ
Bullfrog AI Holdings reported its third quarter 2024 results, highlighting continued investment in its AI platform and drug development programs despite no revenue for the quarter.
NASDAQ
Bullfrog AI Holdings reported its second quarter 2024 results, highlighting continued investment in its AI platform and drug development programs despite no revenue generation for the period.
NASDAQ
Bullfrog AI Holdings reports a net loss of $1.92 million for the first quarter of 2024, despite a $5.7 million boost from a secondary public offering.